Stay updated with breaking news from Service Testing. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
By Denny Jacob Passage Bio shares were 29% higher at 98 cents in premarket trading following initial safety and biomarket data from patients in a clinical...
By Chris Wack Tonix Pharmaceuticals said a Phase 3 study evaluating TNX-102 SL cyclobenzaprine HCl sublingual tablets met its pre-specified primary endpoint...
By Sabela Ojea Immunovant said it received positive data from its ongoing 24-week Phase 2 clinical trial for its batoclimab treatment for Graves' disease....
By Denny Jacob Aldeyra Therapeutics shares rose 12% to $3.31 following news of positive topline results from a Phase 2 clinical trial of ADX-629, a treatment...
By Adriano Marchese Mirum Pharmaceuticals said Monday that data from a Phase 2 trial for its potential biliary atresia treatment Livmarli didn't meet either...